Vitamin C: Oral vs. Intravenous, Immune Effects, Cancer, Exercise Adaptation & More
Key Moments
Vitamin C: Oral vs. IV, immunity, cancer, exercise, and safety.
Key Insights
Oral and intravenous (IV) vitamin C have vastly different bioavailability and plasma concentrations.
Vitamin C is crucial for immune cell function, potentially reducing cold duration and enhancing defense.
IV vitamin C shows promise as an adjunct in cancer treatment and for severe conditions like sepsis.
Vitamin C plays a role in exercise adaptation, though high doses with other antioxidants might blunt benefits.
While generally safe, high doses of vitamin C may pose kidney stone risks in those with pre-existing kidney issues.
Vitamin C influences fatty acid oxidation, potentially aiding in weight management and metabolic health.
INTRODUCTION TO VITAMIN C AND ITS ROLE
Vitamin C, also known as ascorbic acid, is an essential nutrient recognized for its potent antioxidant properties. It combats oxidative stress by donating electrons to neutralize harmful oxidized molecules, thereby protecting vital cellular components like proteins and DNA. Beyond its antioxidant functions, vitamin C acts as a crucial cofactor for numerous enzymes, supporting critical physiological processes such as immune function, wound healing, and neurotransmitter synthesis. Unlike most animals, humans cannot synthesize vitamin C, necessitating its intake through diet or supplements.
DIETARY SOURCES, RECOMMENDED INTAKE, AND DEFICIENCY
Rich sources of vitamin C include guavas, kiwis, and bell peppers, though cooking can diminish content by over 25%. Meat is generally a poor source. Recommended daily intake (RDA) varies by age and life stage, with adult men needing 90mg and women 75mg. Smokers and alcohol drinkers have higher needs due to increased oxidative stress and urinary losses. Deficiency leads to scurvy, characterized by bleeding gums, poor wound healing, and fatigue, typically manifesting with intakes below 10mg daily.
BIOAVAILABILITY: ORAL VS. INTRAVENOUS ADMINISTRATION
The bioavailability of vitamin C differs significantly between oral and intravenous (IV) administration. Oral intake saturates at 220 micromoles/liter plasma concentration, even with high doses. IV administration, however, can achieve concentrations up to 15,000 micromoles/liter, over 68 times higher than oral routes. This dramatic difference is due to IV vitamin C bypassing intestinal absorption and saturable transport mechanisms, making it a powerful tool for achieving therapeutic levels in specific conditions.
VITAMIN C AND IMMUNE FUNCTION
Vitamin C is concentrated in immune cells, particularly neutrophils and leukocytes, where it protects against self-inflicted damage from reactive oxygen species (ROS) generated during pathogen defense. It supports T cell proliferation and prevents cell death, crucial for adaptive immunity. Emerging research suggests vitamin C can modulate cytokine levels, reducing pro-inflammatory responses. While consistent effects on preventing the common cold are debated, higher doses (2g/day) show promise in reducing cold duration, especially in children and endurance athletes.
RESPIRATORY HEALTH AND EXERCISE ADAPTATION
Vitamin C may protect the lungs by enhancing immune function and reducing oxidative stress, potentially lowering the risk of respiratory diseases and lung cancer. It has shown promise in reducing the duration of mechanical ventilation for patients with respiratory failure, particularly those on ventilators for over 24 hours. Regarding exercise, vitamin C might mitigate exercise-induced bronchoconstriction and muscle damage. However, high doses combined with other antioxidants like vitamin E could potentially blunt beneficial training adaptations, such as mitochondrial biogenesis.
METABOLIC HEALTH AND NEUROPROTECTION
Vitamin C influences fatty acid oxidation, vital for energy utilization. Lower vitamin C levels correlate with higher body fat, and supplementation may improve fat metabolism. Studies suggest vitamin C is crucial for brain development and function, retaining high concentrations even during deficiency. Its antioxidant properties may offer neuroprotection against diseases like Alzheimer's and Parkinson's by reducing oxidative damage in the brain.
INTRAVENOUS VITAMIN C IN SEVERE CONDITIONS AND CANCER THERAPY
IV vitamin C is increasingly explored for severe health conditions. It shows potential in treating sepsis by preserving organ function and reducing mortality, though results vary across studies. As an adjunct to chemotherapy, high-dose IV vitamin C, as proposed by Linus Pauling, may improve quality of life, reduce treatment side effects, and potentially influence survival rates, although large-scale controlled trials are still needed to confirm efficacy for specific cancers and regimens.
FERTILITY, CARDIOVASCULAR HEALTH, AND INFLAMMATION
Vitamin C plays a role in male fertility by decreasing reactive oxygen species and improving sperm quality. Population studies suggest vitamin C intake may protect against high blood pressure, with IV infusions showing acute blood pressure reduction. It also modulates the inflammatory response, potentially lowering C-reactive protein levels, an indicator of cardiovascular disease risk, suggesting broader benefits for systemic inflammation.
SAFETY CONSIDERATIONS AND KIDNEY STONE RISK
Oral vitamin C is generally safe, with a tolerable upper intake of 2000mg/day to avoid gastrointestinal upset. IV vitamin C is also well-tolerated with minimal side effects. However, individuals with hemochromatosis should exercise caution due to enhanced iron absorption. While high doses of vitamin C have been linked to an increased theoretical risk of kidney stones, particularly in those with pre-existing kidney impairment, large cohort studies suggest this risk is minimal for healthy individuals, with compensatory mechanisms potentially mitigating oxalate buildup.
Mentioned in This Episode
●Supplements
●Software & Apps
●Companies
●Organizations
●Concepts
●People Referenced
Plasma Vitamin C Concentrations: Oral vs. Intravenous
Data extracted from this episode
| Method | Therapeutic Dose | Plasma Concentration (micromoles/liter) |
|---|---|---|
| Dietary Intake (5-9 servings fruit/veg) | N/A | ~80 |
| Maximum Oral Intake (3g x 6 daily) | 3g | ~220 (peak) |
| Intravenous Administration | 1.25g | ~885 |
| Intravenous Administration | 3g | ~1760 (peak) |
| Intravenous Administration (high-dose) | N/A | up to 15,000 |
Vitamin C and Common Cold Duration Reduction
Data extracted from this episode
| Group | Dosage | Cold Duration Reduction |
|---|---|---|
| Adults (Therapeutic) | 2g/day | 21% |
| Adults (Therapeutic) | 1g/day | 6% |
| Children (Therapeutic) | 2g/day | 26% |
| Children (Therapeutic) | 1g/day | 17% |
| Prophylactic + Therapeutic Combo | 1-3g daily, then up to 6g | ~0.5 days reduction |
| Prophylactic Only (Meta-analysis) | 200mg-2g/day | 4% relative risk reduction |
Vitamin C and Mechanical Ventilation Duration
Data extracted from this episode
| Ventilation Duration | Vitamin C Administration | Time Reduction on Ventilation |
|---|---|---|
| > 24 hours | Oral or IV Vitamin C | 18% less time |
| < 24 hours | Oral or IV Vitamin C | No effect |
Vitamin C and Lung Cancer Risk (Men)
Data extracted from this episode
| Factor | Risk Reduction |
|---|---|
| Per 100mg increase in daily intake | 7% decrease |
Vitamin C Supplementation and Exercise Adaptations
Data extracted from this episode
| Intervention | Observed Effect | Notes |
|---|---|---|
| 0.4-3g/day Vitamin C | Decreased muscle damage markers & soreness | Lower doses (0.2-1g/day) showed no effect |
| 1g Vitamin C + 235mg Vitamin E | Blunted mitochondrial biogenesis markers | Compared to placebo group; VO2 max similar |
| Antioxidant Cocktail (Vit E, Beta Carotene) + 1g Vitamin C | Increased neutrophil antioxidant defenses | Improved neutrophil function and reduced oxidative damage in lymphocytes |
Vitamin C and Sepsis Mortality
Data extracted from this episode
| Treatment Group | Mortality Rate (28 days) |
|---|---|
| Placebo | ~47-50% |
| IV Vitamin C (50mg/kg q6h x 96h) | <30% |
| IV Vitamin C (6g qid x 4 days) + Hydrocortisone + Thiamine | ~8% |
Vitamin C and Cancer Patient Quality of Life
Data extracted from this episode
| Intervention | Reported Improvements |
|---|---|
| 10g IV Vit C BID + 4g Oral Vit C daily | Physical, emotional, cognitive status; reduced fatigue, nausea, vomiting, pain, appetite loss |
| 7.5g IV Vit C weekly with chemo/radiation | Improved quality of life compared to chemo/radiation alone |
Vitamin C and Male Fertility
Data extracted from this episode
| Intervention | Improvement |
|---|---|
| 1g Oral Vit C twice daily for 2 months | Sperm count increased 58%, motility increased 48% |
Vitamin C and Blood Pressure Reduction
Data extracted from this episode
| Condition | Intervention | Result |
|---|---|---|
| Hypertension | Avg. 500mg Oral Vit C daily for 8 weeks | Significant decrease in blood pressure |
| Prehypertension | IV Vitamin C (15-800g over 80 min) | Acute reduction of 10-15 points (systolic/diastolic) within 10-20 min |
| Prehypertension | IV Vitamin C (doses >30g by 75 min) | Reduced systolic BP by up to 6 points, diastolic by ~7 points |
Vitamin C, Vitamin E, and C-Reactive Protein
Data extracted from this episode
| Intervention | Change in C-Reactive Protein |
|---|---|
| 1g Vitamin C + 800 IU Vitamin E daily | 17% decrease (in individuals with elevated baseline levels) |
Rheumatoid Arthritis and C-Reactive Protein
Data extracted from this episode
| Intervention | Change in C-Reactive Protein |
|---|---|
| Intravenous Vitamin C (varying durations) | 44% decrease |
Vitamin C and Viral Replication (In Vitro)
Data extracted from this episode
| Virus | Vitamin C Concentration | Effect |
|---|---|---|
| Unspecified virus | 150 mcg/mL | Reverse transcriptase activity decreased by 99%; p24 antigen decreased by 13% |
| Influenza | 2.5 mmol/L | Eliminated 90% of virus |
| Influenza | 20 mmol/L | Fully blocked viral replication |
Common Questions
Oral vitamin C absorption is limited by saturable transporters in the small intestine, reaching a peak plasma concentration of around 220 micromoles/liter. Intravenous vitamin C bypasses these limitations, achieving much higher plasma concentrations, potentially up to 15,000 micromoles/liter.
Topics
Mentioned in this video
An inflammatory bowel disease that can increase a person's vitamin C needs.
A form of vitamin C encapsulated in lipid particles, which some studies suggest may increase bioavailability at higher doses.
A narrowing of the airways in response to intense exercise, which supplemental vitamin C might mitigate.
A brain region important for executive functions, where vitamin C is found in high concentrations.
A steroid medication used in combination with vitamin C and thiamine for sepsis treatment in one study, showing improved outcomes.
Mentioned in the context of the Food and Nutrition database which lists the vitamin C content of beef items.
Immune cells that consume large amounts of vitamin C when activated to kill pathogens, and are protected from self-damage by vitamin C.
Forced expiratory volume, a measure of respiratory capacity used to characterize exercise-induced bronchoconstriction.
A marker of muscle damage that was decreased by supplemental vitamin C doses ranging from 400mg to 3g per day post-exercise.
A protein that regulates fat metabolism, levels of which were increased in mice supplemented with vitamin C.
A viral infection where a retrospective study found intravenous vitamin C decreased viral titers and replication.
A leading cause of death, for which high blood pressure is a major risk factor partially mitigated by vitamin C.
A virus that in vitro studies showed dose-dependent killing by vitamin C.
A genetic disorder causing premature aging, where vitamin C supplementation in a mouse model increased lifespan and corrected age-related metabolic diseases.
A toxin to which men exposed showed improved sperm quality after taking vitamin C.
A leading cause of death, for which high blood pressure is a major risk factor partially mitigated by vitamin C.
The chemical name for Vitamin C, an essential nutrient recognized for its antioxidant properties.
Transporters in the small intestine responsible for absorbing oral vitamin C, whose activity is dose-dependent and subject to saturation.
Signaling molecules produced in response to inflammation and infection; vitamin C may help normalize their production.
The body's response to insulin in regulating blood glucose, which may be attenuated by vitamin C supplementation with other antioxidants during exercise.
Blood pressure between 120/80 and 139/89, which intravenous vitamin C has been shown to reduce.
A cytokine that signals the body to initiate antiviral defenses, the production of which vitamin C is involved in.
The oxidized form of vitamin C, which competes with glucose for uptake into cells via glucose transporters.
A viral infection sometimes treated with intravenous vitamin C, with case studies suggesting potential pain reduction.
A life-threatening condition arising from infection, where intravenous vitamin C has shown promise in reducing organ failure and mortality.
A B vitamin used in combination with vitamin C and hydrocortisone for sepsis treatment, showing improved outcomes.
A deficiency where high doses of intravenous vitamin C carry a risk of hemolysis, although lower doses may be safe.
Nucleic acid protected from oxidative damage by vitamin C.
A chronic inflammatory airway disease where vitamin C's role in reducing symptoms and severity has shown mixed results in studies.
Oral and genital herpes, conditions for which intravenous vitamin C is acclaimed as a treatment, though clinical studies are lacking.
A stage of cancer where intravenous vitamin C has been used anecdotally to improve quality of life and reduce symptoms like fatigue and pain.
The process most cancers rely on for energy, which high concentrations of vitamin C might inhibit by reducing glucose uptake.
The classic manifestation of severe vitamin C deficiency, characterized by bleeding gums, poor wound healing, and joint pain.
A neurodegenerative disease where vitamin C's antioxidant capacity may be beneficial.
A neurodegenerative disease where vitamin C's antioxidant capacity may be beneficial.
A cancer treatment for which high-dose intravenous vitamin C can be a supportive therapy, potentially mitigating side effects and improving quality of life.
An inflammatory biomarker associated with cardiovascular disease risk, which vitamin C and E supplementation decreased in individuals with elevated baseline levels.
A condition of abnormally high iron levels where caution is advised with vitamin C supplementation due to improved iron absorption.
A condition where oxalate calcium crystals form in the kidney, observed in patients with kidney impairment given high-dose intravenous vitamin C.
Transporters that can uptake dehydroascorbic acid (oxidized vitamin C), potentially competing with glucose uptake.
A form of magnesium studied alongside vitamin C for asthma, with no observed beneficial effects on asthma control in one study.
A viral infection for which intravenous vitamin C has been used, with case studies suggesting it might reduce pain.
More from FoundMyFitness
View all 92 summaries
2 minWatch my episode with Dr. Charles Brenner
115 minHow To Boost NAD Levels To Fight Inflammation, Improve Recovery, and Slow Aging
92 minDr. Rhonda Patrick: Maximizing Healthspan with Exercise, Sauna, & Cold Exposure
131 minWhy Vigorous Exercise Is 4–10x More Effective Than Moderate (New Evidence)
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free